"The results generated by the UCL sub-study show that those participants receiving molnupiravir cleared SARS-CoV-2 more quickly than those receiving only usual care," said Professor Judith Breuer (UCL GOS Institute of Child Health) about her new research into the antiviral drug.
Read: Evening Standard, More: FT (£)
Close
